Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1978 Dec 15;176(3):727–732. doi: 10.1042/bj1760727

Calcium-dependent protein modulator of cyclic nucleotide phosphodiesterases from mouse epidermis.

A W Murray, A Rogers
PMCID: PMC1186294  PMID: 218552

Abstract

1. A heat-stable modulator protein was partially purified from mouse epidermis. The protein stimulated modulator-depleted cyclic AMP phosphodiesterase from bovine brain in the presence of Ca2+. 2. DEAE-cellulose chromatography of epidermal extracts demonstrated the presence of two main phosphodiesterase activities that hydrolysed both cyclic AMP and cyclic GMP. A minor peak was eluted between 0.1 and 0.3 M-sodium acetate and a major peak was eluted between 0.3 and 0.45 M-sodium acetate. 3. Cyclic AMP phosphodiesterase activity eluted at low salt concentrations was markedly activated by the epidermal modulator protein in the presence of Ca2+. Storage of the enzyme led to a decrease in its sensitivity to the protein modulator. 4. Treatment of mouse skin with the tumour promoter 12-O-tetradecanoylphorbol 13-acetate, which leads to an increase in epidermal cyclic nucleotide phosphodiesterase activity, did not alter the amount of modulator present in soluble epidermal extracts. The tumour promoter decreased the amount of modulator extractable from particulate epidermal preparations with Triton X-100.

Full text

PDF
727

Images in this article

729Fig. 1.
on p.729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi K., Iizuka H., Halprin K. M., Levine V. Specific refractoriness of adenylate cyclase in skin to epinephrine, prostaglandin E, histamine and AMP. Biochim Biophys Acta. 1977 Apr 27;497(2):428–436. doi: 10.1016/0304-4165(77)90200-8. [DOI] [PubMed] [Google Scholar]
  2. Adachi K., Levine V., Halprin K. M., Iizuka H., Yoshikawa K. Multiple forms of cyclic nucleotide phosphodiesterase in pig epidermis. Biochim Biophys Acta. 1976 Apr 8;429(2):498–507. doi: 10.1016/0005-2744(76)90297-7. [DOI] [PubMed] [Google Scholar]
  3. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bergstrand H., Lundquist B. Partial purification and characterization of adenosine- and guanosine-3',5'-monophosphate phosphodiesterases from human lung tissue. Biochemistry. 1976 Apr 20;15(8):1727–1735. doi: 10.1021/bi00653a021. [DOI] [PubMed] [Google Scholar]
  5. Brostrom C. O., Huang Y. C., Breckenridge B. M., Wolff D. J. Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase. Proc Natl Acad Sci U S A. 1975 Jan;72(1):64–68. doi: 10.1073/pnas.72.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheung W. Y., Bradham L. S., Lynch T. J., Lin Y. M., Tallant E. A. Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase. Biochem Biophys Res Commun. 1975 Oct 6;66(3):1055–1062. doi: 10.1016/0006-291x(75)90747-0. [DOI] [PubMed] [Google Scholar]
  7. Gnegy M. E., Costa E., Uzunov P. Regulation of transsynaptically elicited increase of 3':5'-cyclic AMP by endogenous phosphodiesterase activator. Proc Natl Acad Sci U S A. 1976 Feb;73(2):352–355. doi: 10.1073/pnas.73.2.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gnegy M., Uzunov P., Costa E. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors. J Pharmacol Exp Ther. 1977 Sep;202(3):558–564. [PubMed] [Google Scholar]
  9. Grimm W., Marks F. Effect of tumor-promoting phorbol esters on the normal and the isoproterenol-elevated level of adenosine 3',5'-cyclic monophosphate in mouse epidermis in vivo. Cancer Res. 1974 Nov;34(11):3128–3134. [PubMed] [Google Scholar]
  10. Ho H. C., Wirch E., Stevens F. C., Wang J. H. Purification of a Ca2+-activatable cyclic nucleotide phosphodiesterase from bovine heart by specific interaction with its Ca2+-dependent modulator protein. J Biol Chem. 1977 Jan 10;252(1):43–50. [PubMed] [Google Scholar]
  11. Hrapchak R. J., Rasmussen H. Characterization of two forms of beef heart cyclic nucleotide phosphodiesterase. Biochemistry. 1972 Nov 21;11(24):4458–4465. doi: 10.1021/bi00774a006. [DOI] [PubMed] [Google Scholar]
  12. Kumar R., Solomon L. M., Cobb J., Schreckenberger A. Adenosine 3'-5'-monophosphate-dependent protein kinases of neonatal human skin. J Invest Dermatol. 1976 Jan;66(1):14–16. doi: 10.1111/1523-1747.ep12477989. [DOI] [PubMed] [Google Scholar]
  13. Kumar R., Tao M., Piotrowski R., Solomon L. Multiple forms of adenosine 3',5'-cyclic monophosphate-dependent protein kinase from monkey skin. Biochim Biophys Acta. 1973 Jul 5;315(1):66–72. doi: 10.1016/0005-2744(73)90130-7. [DOI] [PubMed] [Google Scholar]
  14. Kumar R., Tao M., Solomon L. M. Cyclic 3',5'-adenosine monophosphate-stimulated protein kinase from human skin. J Invest Dermatol. 1971 Nov;57(5):312–315. doi: 10.1111/1523-1747.ep12292412. [DOI] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Marks F. Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin. Cancer Res. 1976 Jul;36(7 Pt 2):2636–2643. [PubMed] [Google Scholar]
  17. Murray A. W., Froscio M. Effect of tumor promoters on the activity of cyclic adenosine 3':5'-monophosphate-dependent and -independent protein kinases from mouse epidermis. Cancer Res. 1977 May;37(5):1360–1363. [PubMed] [Google Scholar]
  18. Murray A. W., Verma A. K. The adenyl cyclase system and carcinogenesis: decreased responsiveness of mouse epidermis to isoproterenol after 3,4-benzpyrene treatment. Biochem Biophys Res Commun. 1973 Sep 5;54(1):69–75. doi: 10.1016/0006-291x(73)90889-9. [DOI] [PubMed] [Google Scholar]
  19. Sakai T., Yamanaka H., Tanaka R., Makino H., Kasai H. Stimulation of cyclic nucleotide phosphodiesterases from rat brain by activator protein, proteolytic enzymes and a vitamin E derivative. Biochim Biophys Acta. 1977 Jul 8;483(1):121–134. doi: 10.1016/0005-2744(77)90014-6. [DOI] [PubMed] [Google Scholar]
  20. Thompson W. J., Appleman M. M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry. 1971 Jan 19;10(2):311–316. [PubMed] [Google Scholar]
  21. Verma A. K., Froscio M., Murray A. W. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis. Cancer Res. 1976 Jan;36(1):81–87. [PubMed] [Google Scholar]
  22. Voorhees J. J., Chambers D. A., Duell E. A., Marcelo C. L., Krueger G. G. Molecular mechanisms in proliferative skin disease. J Invest Dermatol. 1976 Sep;67(3):442–450. doi: 10.1111/1523-1747.ep12514730. [DOI] [PubMed] [Google Scholar]
  23. Wallace G. A., Harary I. Localization of the cyclic adenosine 3' : 5' -monophosphate phosphodiesterase activator protein in rat heart. Biochem Biophys Res Commun. 1975 Nov 17;67(2):810–817. doi: 10.1016/0006-291x(75)90885-2. [DOI] [PubMed] [Google Scholar]
  24. Watterson D. M., Harrelson W. G., Jr, Keller P. M., Sharief F., Vanaman T. C. Structural similarities between the Ca2+-dependent regulatory proteins of 3':5'-cyclic nucleotide phosphodiesterase and actomyosin ATPase. J Biol Chem. 1976 Aug 10;251(15):4501–4513. [PubMed] [Google Scholar]
  25. Watterson D. M., Van Eldik L. J., Smith R. E., Vanaman T. C. Calcium-dependent regulatory protein of cyclic nucleotide metabolism in normal and transformed chicken embryo fibroblasts. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2711–2715. doi: 10.1073/pnas.73.8.2711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wells J. N., Hardman J. G. Cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res. 1977;8:119–143. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES